All News

Upcoming Events

Scrotoplasty and Dehiscence after Implant Procedures

Scrotoplasty at Time of Penile Implant is at High Risk for Dehiscence in Diabetics

Nikhil K. Gupta MD; Randy Sulaver MD; Charles Welliver MD; Michael Kottwitz MD; Luke Frederick MD; Danuta Dynda MD; Tobias S. Köhler, MD

FIRST PUBLISHED: March 6, 2019 – The Journal of Sexual Medicine


Scientists Compare Intralesional Therapies for Peyronie’s Disease

Comparative Effectiveness of Intralesional Therapy for Peyronie’s Disease in Controlled Clinical Studies: A Systematic Review and Network Meta-Analysis

Giorgio Ivan Russo, MD, PhD; Giovanni Cacciamani, MD; Andrea Cocci, MD; Thomas M. Kessler, MD; Giuseppe Morgia, MD; Ege Can Serefoglu, MD, FECSM; Maarten Albersen, MD, PhD; Paolo Verze, MD, PhD, on behalf of EAU-YAU Men’s Health Working Group

FIRST PUBLISHED: January 25, 2019 – The Journal of Sexual Medicine


Many Penile Girth Enhancement Approaches Considered Experimental

Many men feel anxious and distressed about their penis size and seek medical procedures to increase it. Most men in this situation already have a normal-sized penis (The average length of an erect penis is 13.1 centimeters; the average girth is 11.65 centimeters.)

Surgical Removal of Hard-to-Reach IPP Reservoir: New Technique Discussed

Penile Prosthesis Reservoir Removal: Surgical Description and Patient Outcomes

Jonathan Clavell-Hernández, MD; Samuel G. Aly, MD; Run Wang, MD; Hossein Sadeghi-Nejad, MD

FIRST PUBLISHED: December 12, 2018 – The Journal of Sexual Medicine


Testosterone Therapy and Cardiovascular Risks: Study Details and Analysis

The first of the two recent studies reporting risks with testosterone prescriptions, published in the Journal of the American Medical Association by Vigen et al (1), was a retrospective analysis of a dataset of 8709 men in the VA health system who had undergone coronary angiography. Among men with testosterone concentrations less than 300ng/dl, the authors reported an increased rate of heart attacks, strokes, and deaths in men who received a testosterone prescription compared with men who did not.

Pharmacologic Treatment of Premature Ejaculation

Pharmacologic treatment of premature ejaculation represents a new approach to the treatment of PE and a radical departure from the psychosexual model of treatment. There have been many papers discussing this topic. I chose to write a clinical paper, in the form of Questions and Answers, which is an innovative way of writing an article (with several citations) to help clinicians in the management of premature ejaculation.


Members Only


ISSM Update